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ABSTRACT
Objective: To investigate whether: (1) smoking
predicts suicide-related outcomes (SROs), (2) prior
SRO predicts smoking, (3) smoking abstinence affects
the risk of SRO and (4) psychiatric comorbidity
modiﬁes the relationship between smoking and SRO.
Design: Retrospective analysis of longitudinal data
obtained in wave 1 (2001e2002) and wave 2
(2004e2005) of the National Epidemiologic Survey on
Alcohol and Related Conditions.
Setting: Face-to-face interviews conducted with
persons in the community.
Participants: US adults (N¼43093) aged 18 years or
older were interviewed in wave 1 and reinterviewed
(N¼34653) 3 years later. For the present study, the
sample was the subset of persons (N¼7352) who at
the wave 2 interview reported low mood lasting
2 weeks or more during the past 3 years and were
further queried regarding SRO occurring between
waves 1 and 2.
Outcome measures: SRO composed of any of the
following: (1) want to die, (2) suicidal ideation, (3)
suicide attempt, reported at wave 2. Current smoking
reported at wave 2.
Results: Current and former smoking in wave 1
predicted increased risk for wave 2 SRO independently
of prior SRO, psychiatric history and socio-
demographic characteristics measured in wave 1
(adjusted OR (AOR)¼1.41, 95% CI 1.28 to 1.55 for
current smoking; AOR¼1.32, 95% CI 1.21 to 1.43 for
former smoking). Prior SRO did not predict current
smoking in wave 2. Compared with persistent never-
smokers, risk for future SRO was highest among
relapsers (AOR¼3.42, 95% CI 2.85 to 4.11), next
highest among smoking beginners at wave 2
(AOR¼1.82, 95% CI 1.51 to 2.19) and lowest among
long-term (4+ years) former smokers (AOR¼1.22,
95% CI 1.12 to 1.34). Compared with persistent
current smokers, risk for SRO was lower among
long-term abstainers (p<0.0001) but not among
shorter-term abstainers (p¼0.26).
Conclusions: Smoking increased the risk of future
SRO independently of psychiatric comorbidity.
Abstinence of several years duration reduced that risk.
INTRODUCTION
Suicide is a leading cause of death worldwide.
Close to 1 million persons die of suicide
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To investigate among persons reporting low mood
lasting 2 weeks or more during the past 3 years
whether:
- smoking predicts SROs (want to die, suicidal
ideation, suicide attempt); prior SROs predict
smoking;
- smoking abstinence affects the risk of SROs;
- psychiatric comorbidity modiﬁes the relationship
between smoking and SROs.
Key messages
- Current and former smoking (<4 years’ reported
abstinence) predicted increased risk for SROs
independently of prior SROs, psychiatric history
and socio-demographic characteristics.
- Prior SROs did not predict future current
smoking.
- Compared with persistent current smokers, risk
of SROs was reduced with long-term ($4 years)
but not with shorter-term (<4 years) abstinence.
Strengths and limitations of this study
- Face-to-face interviews, a longitudinal design,
a large representative sample, a validated diag-
nostic instrument, a comprehensive range of
putative predictors that permitted statistical
control of the key background factors and
comorbidities.
- Only persons with self-reported low mood were
questioned about SROs; consequently, no
generalisability to other populations.
- The sample did not include persons who had
completed suicide.
- No assessment of the effects of medical
conditions that are possibly causally related to
smoking and to SROs.
- Smoking information was self-reported, not
biologically veriﬁed.
- No information from adolescents, a high-risk
population for both smoking and SROs.
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Open Access Researcheach year. The WHO predicts that by 2020 suicide deaths
will rise to 1.5 million.
1 Completed suicides are largely
predicted by the wish to die, thoughts of suicide and
unsuccessful previous suicidal attempts,
2 making it im-
portant to understand the risks posed by suicide-related
outcomes (SROs). A history of mental disorders
3e5 and
particular demographic characteristics (female gender,
younger age, unmarried status and unemployment) are
putative risk factors for suicide and SRO.
2 Smoking, long
known as a major risk factor for numerous medical ill-
nesses,
6 and recently, for psychiatric outcomes as well,
78
has received increasing attention for its potential con-
tribution to the risk of completed suicides and SROs.
9
Nevertheless, whether the association between smoking
and suicidal behaviours is causal or correlational remains
unclear.
A link between smoking and suicide was observed as
early as 1976 by Doll and Peto
10 in their study of mortality
due to smoking in male British doctors. Clinical and
epidemiological studies that subsequently investigated
the issue are in general, but not universal, agreement in
ﬁnding a signiﬁcant association between smoking and
suicide and suicidal behaviours. Among studies that
focused on SRO, three that used cross-sectional epide-
miological data found a positive correlational association
between smoking and SRO.
11e13 Of seven longitudinal
studies that also used community-based data, three
14e16
found that current smoking predicted suicidal behaviours
even after controlling for the effects of demographic and
psychiatric variables; four studies did not ﬁnd a positive
relationship.
17e20
The effect of smoking abstinence on risk of SRO is also
unclear. A study of young adults followed for 10 years
found that recent, but not presurvey, cigarette smoking
predicted suicidal thoughts and attempts.
14 Another
study showed higher incidence rates of suicidal ideation
among former smokers than never smokers, but the dif-
ference was no longer signiﬁcant after adjustment with
depressive disorder, anxiety symptoms and alcohol depen-
dence.
16 A study based on wave 1 data from the National
Epidemiological Survey of Alcohol and Related Conditions
(NESARC) initially found that longer duration of absti-
nence decreased risk for SRO, but this effect disappeared
upon controlling for psychiatric comorbidity.
21
A further question of theoretical and practical impor-
tance is whether prior SRO increases the risk of future
smoking. In the single study that has addressed this
question, longitudinal data obtained from adolescents
showed that smoking predicted suicidal ideation and
suicide attempts, but prior suicidality was not associated
with subsequent smoking.
15
The present study was conducted to address these con-
undrums of the smokingesuicide relationship: (1) whether
prior smoking predicts SRO; (2) whether prior SRO
predicts smoking; (3) whether smoking cessation and its
corollary, duration of smoking abstinence, affects risk for
SRO and (4) whether these relationships are independent
of comorbid psychiatric illness. Also explored were the
effects of smoking status changes between the two waves of
the NESARC on risk of future SRO. The two-wave format,
the large sample and extensive data on psychiatric com-
orbidity that characterised the NESARC
22 permitted
assessment of these questions.
The survey instrument had asked questions regarding
the past occurrence of SROdwant to die, suicidal ideation
and suicide attempt, only of persons reporting low mood.
This restriction limits the generalisability of ﬁndings to the
general population, but the much higher occurrence of
suicidal behaviours among persons with low mood
3 4
provided a more sensitive context for detecting the risk




The NESARC data were collected to obtain a representa-
tive national sample of US adults. In wave 1 (2001e2002),
face-to-face interviews were completed with 43093
persons aged 18 years or older. The overall response rate
was 81.0%. The wave 1 sample was reinterviewed in wave 2
(2004e2005) 3 years later (mean interval ¼36.6 months,
SE¼2.62), with a response rate of 80.4% (N¼34653)
based on the wave 1 sample. The NESARC sample size
was chosen to be sufﬁciently large to produce nationally
representative proportions for the study of substance
abuse and dependence and mental disorders by demo-
graphic group with CIs equal to or smaller than extant
studies. Following NESARC guidelines,
24 25 the original
NESARC data set was transformed to account for survey
design effects and sampling weights upon responses in
order to adjust for sample selection procedures, non-
response from selected households or individuals, over-
sampling (of young adults, blacks and Hispanics) and
non-response at the wave 2 time point. Those weights and
survey design effects, employed in other studies based on
NESARC data, as well as other methodological details of
waves 1 and 2 are described in published NESARC Source
and Accuracy Statements.
24 25
Data for the present study were obtained from a subset
of persons (N¼7352) who reported low mood at the
wave 2 interview, irrespective of low mood in wave 1. This
subsample was selected for the present analysis because
it produced the largest number of persons from whom
evaluable information for predicting wave 2 SRO was
available. The latter subsample is also referred to herein
as the ‘at-risk sample’. Persons who did not report low
mood were skipped out of the SRO sections in waves 1
and 2. The questions for low mood at the wave 2 inter-
view were: “Since your LAST interview in (month/year),
have you ever had a time when you felt sad, blue,
depressed, or down most of the time for at least
2 weeks?” and “Since your LAST interview, have you ever
had a time, lasting at least 2 weeks, when you didn’t care
about the things that you usually cared about, or when
you didn’t enjoy the things you usually enjoyed?” At the
wave 1 interview, respondents were asked these same
questions referenced to their entire lifetime.
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Smoking and suicidal behavioursVariables
The outcome variables for this study were wave 2 SRO
and wave 2 current smoking. The main covariates were
prior SRO and smoking status at wave 1. The individual
SRO questions are: “During that time when (your mood
was at its [sic] lowest/you enjoyed or cared the least
about things), did you.feel like you wanted to die? think
about committing suicide? attempt suicide?” Responses
to these items were summed to create the total SRO
question and measured as a dichotomous variable (none
of the three ¼ 0; any of the three ¼ 1). Respondents
who did not report low mood in wave 1 and were not
asked the SRO questions were assigned a value of 0 for
prior SRO.
The questions on tobacco use at wave 1 are: “In your
ENTIRE LIFE, have you ever . (1) Smoked at least 100
cigarettes? (2) Smoked at least 50 cigars? (3) Smoked
a pipe at least 50 times? (4) Used snuff, such as Skoal,
Skoal Bandit [sic] or Copenhagen at least 20 times? (5)
Used chewing tobacco, such as Redman, Levi Garrett or
Beechnut at least 20 times?” Persons who smoked ciga-
rettes, cigars and/or pipes comprised (a weighted)
95.9% (3368/3497) of all tobacco users. Following the
coding rule of the NESARC, all tobacco users, including
the 129 persons who reported using snuff or chewing
tobacco only, were labelled as ‘smokers’. A never smoker
had responded ‘No’ to each of the questions regarding
lifetime use of at least 100 cigarettes, at least 50 cigars,
smoked a pipe at least 50 times, used snuff at least 20
times and used chewing tobacco at least 20 times. A
former smoker was a ‘Yes’ responder to at least one of the
prior questions who also reported that he or she had
not smoked or used tobacco in the past 12 months.
(N.B. Very few, if any, of this latter group would have
been experiencing withdrawal; thus, the current study is
not an adequate test of post-cessation withdrawal as a
predictor of SRO). A current smoker was a ‘Yes’ respon-
dent who had smoked or used tobacco within the past
12 months. At the wave 2 interview, these same questions
on tobacco use were asked with regard to the period
since the last interview (in month/year).
The smoking status variable (ie, never, former,
current) rather than Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV) deﬁned
nicotine dependence was selected to assess tobacco use
because: (1) the adequacy of the DSM-IV criteria as
a valid measure of nicotine dependence remains
controversial
26 27 and (2) response to the single question
on smoking status is easier to elicit in the clinical setting,
with more validity, than responses to a multi-item
measure of tobacco use for which no consensus, stand-
alone instrument yet exists.
26 27 To categorise long-term
or recent status as never-, former, or current smokers,
a change variable was created with the following cate-
gories according to their report of smoking at waves 1
and 2: (1) never smoker to never smoker, (2) former
smoker to former smoker, (3) current smoker to former
smoker, (4) current smoker to current smoker, (5) never
smoker to current smoker, (6) former smoker to current
smoker and (7) never smoker to former smoker.
Other potential confounders or effect modiﬁers because
of their known correlations with smoking and/or SRO,
measured at wave 1, were: demographic characteristics
(age, gender, race/ethnicity, marital status, education,
employment status, income, urban residence, geographic
region) and lifetime measures of DSM-IVAxis I and Axis II
disorders. The Axis I disorders were categorised into mood
disorders (major depression, dysthymia, bipolar I and
bipolar II), anxiety disorders (panic disorder, social
phobia, speciﬁc phobia, generalised anxiety), alcohol use
disorders (alcohol abuse or dependence) and other
substance use disorders (drug abuse or dependence).
Ah i s t o r yo fa t t e n t i o nd e ﬁ c i t hyperactivity disorder
(ADHD), queried only at wave 2, was used among the
wave 1 predictors, its lifetime quality presumed since the
DSM-IV criteria for ADHD include the presence of ADHD
symptoms before age 7. All 10 of the Axis II personality
disorders measured in Alcohol Use Disorder and Associ-
ated Disabilities Interview Schedule (AUDADIS-IV) (shown
in table 1), measured at wave 1, were included as well.
Assessment
For both waves 1 and 2, the AUDADIS-IV was adminis-
tered by interviewers from the US Census Bureau. The
reliability and validity of the DSM-IV diagnoses obtained
through the AUDADIS-IV have been demonstrated in




Weighted percentages and SEs measured the distribu-
tion of the covariates (demographic characteristics and
lifetime psychiatric variables) reported at wave 1 for the
sample with low mood and for the complementary
sample of persons with no low mood. c
2 Tests were
used to assess differences between comparison groups,
for example, the at-risk sample and the complementary
sample of NESARC participants who did not report low
mood. Unadjusted and adjusted ORs (OR and AOR)
and 95% CIs were calculated from univariate logistic
regressions and multivariate logistic regressions, respec-
tively, to assess prediction of wave 2 SRO in the sample of
persons reporting low mood. The incidence of SRO at
wave 2 (since the wave 1 interview) by smoking status,
prior SRO and all other covariates at wave 1 were also
calculated. The opposite temporal relationship of prior
SRO (reported in wave 1) on future current smoking
(reported in wave 2) was tested using the identical
covariates for assessing predictors of wave 2 SRO,
following Granger.
29 All models were estimated with the
PROC SURVEYLOGISTIC function of SAS statistical
software V.9.2, with the results veriﬁed through an
internal statistical review at the US Census Bureau.
Missing values were replaced through imputation using
assignment and allocation methods as described in the
NESARC Source and Accuracy Statements.
24 25 Sensitivity
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Sample size 34653 7352 27301
Smoking status
Current smoker 27.02 0.17 31.65 0.38 25.85 0.19
Former smoker 19.58 0.16 17.84 0.28 20.02 0.17
Never smoker 53.40 0.19 50.51 0.42 54.13 0.20
Wave 1 suicide-related
outcomes
11.42 0.10 25.55 0.27 7.84 0.10
Want to die 10.17 0.10 23.35 0.26 6.82 0.10
Suicidal ideation 8.42 0.09 19.27 0.27 5.66 0.09
Suicide attempt 2.35 0.04 6.09 0.17 1.40 0.04
Demographics
Gender
Female 52.08 0.16 64.13 0.40 49.02 0.17
Male 47.92 0.16 35.87 0.40 50.98 0.17
Race/ethnicity
White 70.93 0.24 71.39 0.40 70.81 0.25
Black 10.75 0.20 10.61 0.22 10.79 0.21
Hispanic 11.56 0.10 11.20 0.15 11.65 0.12
Asian/Pac. Islander 4.36 0.06 3.50 0.10 4.58 0.06
Amer. Indian/Alaska
Native
2.40 0.11 3.29 0.20 2.17 0.11
Age (years)
18e19 4.02 0.07 4.47 0.15 3.91 0.08
20e29 17.78 0.14 19.28 0.30 17.40 0.15
30e44 30.90 0.17 32.28 0.29 30.54 0.18
45e64 31.08 0.15 31.64 0.24 30.94 0.17
65 and older 16.22 0.10 12.32 0.25 17.21 0.12
Household income
<$20000 20.35 0.17 25.07 0.32 19.15 0.19
$20000e$34999 19.62 0.13 20.84 0.27 19.31 0.15
$35000e$59999 26.27 0.16 24.85 0.31 26.63 0.17
$60000 and over 33.76 0.16 29.24 0.33 34.91 0.17
Marital status
Married 59.81 0.17 54.75 0.35 61.10 0.17
Cohabiting 3.25 0.06 3.60 0.11 3.16 0.07
Widowed 6.04 0.07 5.37 0.12 6.21 0.08
Divorced 8.45 0.06 10.73 0.19 7.87 0.07
Separated 1.98 0.04 2.98 0.12 1.73 0.04
Never married 20.46 0.17 22.57 0.33 19.93 0.17
Education
Less than high school 14.65 0.13 16.25 0.26 14.24 0.14
High school diploma 29.03 0.18 29.35 0.35 28.95 0.20
College 56.32 0.22 54.40 0.38 56.81 0.23
Unemployed 7.16 0.09 12.31 0.25 5.85 0.09
Not unemployed 92.84 0.09 87.69 0.25 94.15 0.09
Urban 28.89 0.26 30.59 0.41 28.46 0.25
Rural/not in central city 71.11 0.26 69.41 0.41 71.54 0.25
Northeast 19.67 0.08 18.57 0.15 19.95 0.10
Midwest 23.15 0.16 23.52 0.32 23.05 0.21
South 35.21 0.15 34.89 0.39 35.29 0.19
West 21.97 0.11 23.02 0.23 21.71 0.15
Lifetime psychiatric disorders
Axis I disorders
Alcohol use 30.43 0.20 33.57 0.39 29.63 0.20
Substance use 10.42 0.11 15.06 0.26 9.25 0.11
Nicotine dependence 17.47 0.13 24.33 0.37 15.73 0.13
Anxiety disorder 17.88 0.17 31.00 0.34 14.55 0.17
Continued
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Smoking and suicidal behavioursanalyses were performed that included: comparison of
the at-risk subsample to the complementary wave 2
NESARC sample; using different sets of control variables
with and without education, and census region; and
including help-seeking behaviour controls. In response to
reviewer concerns, we performed the multiple logistic
regression models for assessing prediction of wave 2 SRO
and of wave 2 current smoking based on the unweighted
data adjusted for design effects. These various sensitivity
analyses did not alter the associations between smoking
and SRO reported below.
RESULTS
Wave 1 characteristics
Table 1 shows weighted percentages by smoking status,
SRO taken together and individually, demographic
characteristics and psychiatric disorders (DSM-IV Axis I
and Axis II) in the sample of persons reporting low
mood at wave 1 and the rest of the NESARC sample.
Current smoking, SRO and the prevalence of psychiatric
disorders were markedly higher among the low mood
sample, conﬁrming their at-risk status. Other demo-
graphic characteristics previously associated with higher
risk of suicide and SROs were also higher in the low
mood subsample: more females, more low-income and
fewer high-income responders, fewer married and more
separated or never married, and more unemployed
individuals. Differences by race/ethnicity, age, urban or
rural residence and geographic area were also observed.
Effects of wave 1 characteristics on wave 2 SRO
From here on, reported statistics are for the sample of
persons reporting low mood at wave 2. The overall
incidence rate of SRO (occurring between the wave 1
and wave 2 interviews) was 28.2% (SE ¼ 0.33%). Table 2
shows weighted percentages and ORs for wave 2 SRO by
smoking history, prior SRO and the control variables as
reported in wave 1. Unadjusted ORs and 95% CI for
future SRO are shown as reference points. The AORs
and 95% CIs show signiﬁcantly higher risk of wave 2 SRO
for both wave 1 current smokers (AOR¼1.41, 95%
CI 1.28 to 1.55) and former smokers (AOR¼1.32, 95%
CI 1.21 to 1.43) relative to never smokers. The difference
in point estimates of risk between current versus former
smokers was not signiﬁcant (c
2¼1.95, p¼0.16).
The multivariate model showed that SRO in wave 1 is
the strongest predictor of a wave 2 SRO (AOR¼3.49, 95%
CI 3.18 to 3.84). Signiﬁcant independent risk of future
SRO was also observed for individuals who were woman,
Hispanic, younger, cohabiting, divorced or separated, of
lower income, unemployed and resided outside the
Northeast region. Of the DSM-IV Axis I disorders, only
anxiety (AOR¼1.08, 95% CI 1.01 to 1.17) and ADHD
(AOR¼1.56, 95% CI 1.36 to 1.79) showed signiﬁcantly
elevated risk of wave 2 SRO; mood disorder was corre-
lated with reduced wave 2 SRO risk (AOR¼0.77, 95% CI
0.70 to 0.84). Three of the DSM-IV Axis II disorders, that
is, borderline personality, schizotypal and avoidant person-
ality, showed signiﬁcantly increased risk for wave 2 SRO.
Smoking status change from wave 1 to wave 2
The great majority of the sample (90.5%) did not change
their smoking status as never-, former, or current smoker,
between waves 1 and 2 (table 3). Among the remaining
9.5%, over half (5.3%) had shifted from being current
smokers to former smokers; more than a fourth (2.6%)
were never smokers in wave 1 who became current smokers
in wave 2; and a smaller proportion (<2%) who were
former smokers in wave 1 relapsed to smoking in wave 2.
Effects on wave 2 SRO
Table 3 shows AORs indicating signiﬁcant risk for SRO









Mood disorder 21.09 0.13 41.82 0.33 15.82 0.13
Attention deﬁcit
hyperactivity disorder
2.51 0.06 5.82 0.19 1.67 0.05
Axis II disorders
Borderline 5.89 0.08 18.44 0.28 2.70 0.07
Schizotypal 3.93 0.06 11.20 0.24 2.09 0.05
Narcissistic 6.18 0.08 11.88 0.23 4.74 0.08
Avoidant 2.32 0.05 6.14 0.17 1.36 0.05
Antisocial 3.63 0.07 5.86 0.21 3.07 0.07
Dependent 0.43 0.02 1.36 0.09 0.19 0.01
Obsessive-compulsive 8.07 0.10 13.50 0.31 6.69 0.09
Paranoid 4.33 0.07 9.66 0.21 2.98 0.06
Schizoid 3.06 0.06 6.44 0.21 2.21 0.05
Histrionic 1.80 0.04 3.68 0.15 1.32 0.04
*The sampling weight variable in wave 2 was used.
yRespondents in NESARC wave 2 who reported low mood lasting 2 weeks or more during the 3-year interval covered in the wave 2 NESARC
and were asked the three suicidal behaviour questions.
zRespondents in NESARC wave 2 who did not report low mood and were not asked the three suicidal questions.
NESARC, National Epidemiological Survey of Alcohol and Related Conditions.
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Smoking and suicidal behavioursTable 2 Weighted percentage of suicide-related outcomes (SRO)* reported in wave 2 by wave 1 characteristics, and unadjusted
ORs and AORs for risk of wave 2 SRO among persons reporting low mood at the NESARC wave 2 interview (N¼7352)y
Variable n/N
Weighted percentage
of wave 2 SRO SE ORz (95% CI) AORx (95% CI)
Smoking history
Current smoker in wave 1 809/2217 35.73 0.64 1.77 (1.64 to 1.90) 1.41 (1.28 to 1.55)
Former smoker in wave 1 339/1280 26.68 0.67 1.16 (1.07 to 1.25) 1.32 (1.21 to 1.43)
Never smoker in wave 1 981/3855 23.94 0.43 1.00 1.00
SRO in wave 1 1009/1940 50.01 0.76 3.84 (3.60 to 4.10) 3.49 (3.18 to 3.84)
Demographics
Gender
Female 1488/5090 28.51 0.36 1.05 (0.98 to 1.12) 1.13 (1.04 to 1.22)
Male 641/2262 27.54 0.59 1.00 1.00
Race/ethnicity
White 1253/4295 28.38 0.36 1.00 1.00
Black 333/1352 26.53 0.70 0.91 (0.84 to 0.99) 0.84 (0.76 to 0.92)
Hispanic 438/1342 30.33 0.52 1.10 (1.04 to 1.17) 1.26 (1.16 to 1.36)
Asian/Paciﬁc Islander 47/169 22.68 0.84 0.74 (0.67 to 0.82) 0.93 (0.82 to 1.06)
American Indian 58/194 27.18 2.81 0.94 (0.71 to 1.25) 0.69 (0.51 to 0.92)
Age (years)
18e19 94/264 36.65 1.73 1.00 1.00
20e29 410/1287 31.40 0.67 0.83 (0.69 to 0.98) 0.77 (0.63 to 0.94)
30e44 750/2438 29.32 0.62 0.75 (0.64 to 0.88) 0.73 (0.60 to 0.90)
45e64 679/2395 26.82 0.63 0.66 (0.56 to 0.78) 0.69 (0.56 to 0.84)
65 and older 196/968 20.90 0.93 0.47 (0.39 to 0.57) 0.68 (0.54 to 0.86)
Marital status
Married 836/3309 24.87 0.49 1.00 1.00
Cohabiting 86/230 35.58 1.67 1.67 (1.42 to 1.96) 1.27 (1.07 to 1.51)
Widowed 128/562 24.26 1.09 0.97 (0.85 to 1.10) 0.92 (0.78 to 1.07)
Divorced 390/1104 36.01 0.84 1.70 (1.57 to 1.84) 1.20 (1.10 to 1.32)
Separated 130/338 37.93 1.78 1.85 (1.58 to 2.15) 1.29 (1.06 to 1.56)
Never married 559/2129 30.87 0.69 1.35 (1.24 to 1.46) 0.97 (0.87 to 1.09)
Education
Less than high school 440/1358 31.58 0.92 1.17 (1.04 to 1.32) 1.09 (0.95 to 1.25)
High school diploma 606/2111 28.27 0.74 1.00 1.00
Some college or more 1083/3883 27.08 0.35 0.94 (0.87 to 1.02) 1.08 (1.00 to 1.17)
Lifetime psychiatric disorder
Axis I disorders
Alcohol use 811/2350 32.74 0.60 1.40 (1.31 to 1.49) 0.95 (0.87 to 1.04)
Substance use 427/1033 38.42 0.94 1.75 (1.61 to 1.89) 0.98 (0.88 to 1.09)
Anxiety 843/2278 37.57 0.60 1.72 (1.62 to 1.83) 1.08 (1.01 to 1.17)
Mood 1217/3151 36.62 0.48 2.04 (1.92 to 2.17) 0.77 (0.70 to 0.84)
Attention deﬁcit
hyperactivity disorder
208/394 51.14 1.42 2.87 (2.56 to 3.22) 1.56 (1.36 to 1.79)
Axis II disorders
Borderline 821/1433 55.75 0.79 4.49 (4.22 to 4.77) 2.91 (2.69 to 3.16)
Schizotypal 485/886 53.41 1.26 3.44 (3.09 to 3.84) 1.50 (1.31 to 1.72)
Narcissistic 443/993 42.49 1.01 2.08 (1.89 to 2.29) 1.03 (0.92 to 1.14)
Avoidant 245/446 51.87 1.37 2.97 (2.66 to 3.32) 1.29 (1.05 to 1.58)
Antisocial 188/395 41.55 1.39 1.89 (1.68 to 2.13) 0.85 (0.72 to 1.01)
Dependent 58/90 56.90 2.90 3.44 (2.74 to 4.30) 1.04 (0.76 to 1.41)
Obsessive-compulsive 377/961 36.07 1.05 1.53 (1.39 to 1.69) 0.90 (0.80 to 1.00)
Paranoid 364/756 45.74 1.16 2.37 (2.14 to 2.62) 0.95 (0.82 to 1.10)
Schizoid 210/473 43.81 1.26 2.10 (1.89 to 2.33) 1.01 (0.88 to 1.16)
Histrionic 129/266 44.42 1.83 2.10 (1.82 to 2.43) 0.76 (0.63 to 0.93)
*SRO: feel like want to die, suicide ideation, suicide attempt; 0 ¼ none, 1 ¼ any SRO.
yMissing observations for speciﬁc variables: race, 43; Hispanic origin, 2; age, 13; marital status, 4; educational attainment, 70; household
income, 2544; unemployed, 28; wave 2 individual SRO, 12e18 ‘unknown’ changed to ‘no’. Treatment of unknown values in determination of
psychiatric diagnosis variables is known only to original NESARC project staff at National Institute on Alcohol Abuse and Alcoholism.
zORs and 95% CIs based on simple regression models estimating wave 2 SRO as a function of an individual predictor variable.
xAORs and 95% CIs based on a multiple logistic regression estimating wave 2 SRO as a function of age, sex, race/ethnicity, marital status,
income, education, unemployed status, Census region, urban residence, smoking status, Axis I and Axis II disorders (as described in text) and
lifetime SRO prior to wave 1.
AOR, adjusted OR; NESARC, National Epidemiological Survey of Alcohol and Related Conditions; SRO, suicide-related outcome.
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Smoking and suicidal behaviourspersistent never smokers. The highest risk was seen
for relapsers (former smoker to current smoker)
(AOR¼3.42, 95% CI 2.85 to 4.11); new smokers (never-
smoker to current smoker) showed the next highest risk
(AOR¼1.82, 95% CI 1.51 to 2.19); and long-term former
smokers (during both wave 1 and 2) showed the least
elevated, yet still signiﬁcant, risk (AOR¼1.22, 95%
CI 1.12 to 1.34). The seventh category consisting of
never smokers in wave 1 who reported former smoker
status in wave 2 was too small for a valid analysis.
Comparative risks by abstinence duration, relapse and new
smoking
Pair-wise c
2 tests for equality of coefﬁcients permitted a
comparison of risk estimates for wave 2 SRO (shown in
table 3) between categories of smoking status change.
Given the 3-year interval between waves 1 and 2 and the
coding requirement that former smoking status is as-
signed only upon reporting of at least 12 months of ab-
stinence, long-term former smokers (category 2, table 3)
would have been abstinent for at least 4 years. Persons
who shifted from current smoking in wave 1 to former
smoking in wave 2 (category 3, table 3) would have been
abstinent for at least 12 months and a maximum of
4 years.
The analysis showed that the AOR for wave 2 SRO
among recent former smokers (category 3) did not
differ from persistent current smokers (category 4)
(c
2 (1)¼1.26, p¼0.26). However, long-term former
smokers (category 2) showed a signiﬁcantly lower AOR
for wave 2 SRO than persistent current smokers (c
2 (1)¼
16.9, p<0.0001). These data suggest that a reduction in
risk for future SRO with past smoking becomes apparent
after a considerable period of abstinence. Of additional
interest were the risk estimates associated with re-starting
(ie, relapse) and with beginning to smoke in wave 2.
Compared with persistent current smokers, the AOR for
wave 2 SRO was signiﬁcantly higher for both relapsers
(c
2 (1) ¼56.00, p<0.0001) and smoking beginners in
wave 2 (c
2 (1) ¼4.11, p¼0.04). Furthermore, the AOR
for wave 2 SRO was signiﬁcantly higher among relapsers
than beginning smokers (c
2 (1)¼19.0, p<0.0001).
Does prior SRO predict smoking?
A multiple regression model on current smoking in wave 2
was ﬁt using the identical list of control variables for pre-
dictingwave2SRO.Thissecondmodeldidnotshowadirect
effectofpriorSROonwave2currentsmoking.Personswith
wave 1 SRO were less likely to report current smoking status
atwave2thanwerepersonswhodidnotexperienceSROin
wave 1 (AOR¼0.81, 95% CI 0.72 to 0.90).
To understand the temporal relationship between
smoking and SRO, the effects of the interaction of wave
1 smoking status (current vs never smoker and former vs
never smoker) with history of SRO were examined. Table
4 shows AORs from separate multiple regression models
on SRO and on current smoking in wave 2 for combined
effects of smoking status and prior SRO reported in
wave 1. Never smokers without a prior SRO at wave 1
comprised the reference group in each model. These
analyses did not fundamentally change the ﬁnding that
smoking predicts increased risk of SRO and that the
reverse relationship does not hold but indicates nuanced
impact of both SRO and smoking history.
The model on wave 2 SRO (table 4, section a) shows
that other characteristics (eg, demographics and
psychopathology) being equal: (1) all combinations of
smoking status and SRO history had statistically signiﬁ-
cant risks for wave 2 SRO relative to never smokers
without prior SRO and (2) for each smoking category,
the risks were considerably greater when the combined
group involved a prior SRO. The data also show that
Table 3 Effects on wave 2 suicide-related outcomes (SRO) according to smoking status change as reported in NESARC
wave 1 and wave 2 interviews





1. Consistent never smoker (in wave 1 and wave 2) 897/3653 47.8 (0.40) 1.00
2. Long-term former smoker (in wave 1 and wave 2) 293/1185 16.4 (0.26) 1.22 (1.12 to 1.34)
3. Recent former smoker (current smoker in wave 1,
former smoker in wave 2)
126/393 5.3 (0.14) 1.37 (1.16 to 1.63)
4. Persistent current smoker (in wave 1 and wave 2) 683/1824 26.3 (0.35) 1.50 (1.35 to 1.66)
5. New current smoker (never smoker in wave 1, current
smoker in wave 2)
82/194 2.6 (0.10) 1.82 (1.51 to 2.19)
6. Relapser (former smoker in wave 1, current smoker
in wave 2)
46/95 1.5 (0.08) 3.42 (2.85 to 4.11)
N¼7352x
*The sampling weight variable in wave 2 was used.
yAny of three items: want to die, suicidal ideation, suicide attempt.
zAORs are adjusted OR with 95% CIs based on multiple logistic regression of wave 2 SRO as a function of age, sex, race/ethnicity, marital
status, income, education, unemployed status, Census region, urban residence, smoking status, Axis I and Axis II disorders (as described in
text) and lifetime SRO reported in wave 1.
xThe seventh group (n¼8), which consisted of persons who were never smokers in wave 1, began to smoke and then stopped smoking in wave
2, was too small for a valid assessment of risk.
NESARC, National Epidemiological Survey of Alcohol and Related Conditions.
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Smoking and suicidal behavioursformer smoking and current smoking, in the absence
of prior SRO, are valid predictors of an initial SRO.
However, once a person has had a SRO, smoking status
history does not change the risk predictiondthe risk of
recurrence is fully predicted by that prior SRO and the
other characteristics. The second model, on wave 2
current smoking (table 4, section b), shows an expect-
edly substantial likelihood of being a current smoker in
wave 2 for current smokers in wave 1, regardless of SRO
history. Of interest, prior SRO predicted a contrasting
reduction in the likelihood of smoking uptake in wave 2
for former smokers and never smokers.
DISCUSSION
The main ﬁndings from the present sample of persons
reporting low mood are: (1) current and past smoking
predicted increased risk for SRO independently of
demographics, psychiatric factors and prior SRO; (2)
long-term smoking abstinence was associated with lower
risk than persistent smoking; (3) new smoking due to
relapse after a period of abstinence or to initiation of
smoking by erstwhile never smokers was associated with
an increased risk of SRO relative to persistent smoking;
(4) prior SRO did not increase the risk of future smoking.
For three Axis I disorders, that is, mood, alcohol use
and substance use, the AORs indicated either insigniﬁ-
cant effects or a decreased risk of future SRO. These
results differ from the increased risks found in the
unadjusted analyses, indicating confounding effects of
correlated predictors of SRO, for example, prior SRO
and comorbid psychiatric disorders.
3e5 In further anal-
ysis that excluded prior SRO in the multivariate model,
a positive predictive effect of mood disorder on future
SRO (AOR¼2.05, 95% CI 1.92 to 2.17) was observed,
contrary to the reduced effect of mood disorder in the
full model that adjusted for prior SRO (results available
upon request). This ﬁnding exempliﬁes an instance
when collinearity with a stronger predictor (eg, wave 1
SRO) overwhelmed the explanatory power of other
predictors with weaker relationships. It is thus remark-
able that signiﬁcant effects of smoking on risk of SRO
remained despite the evidence of effect suppression due
to confounding. Ranked in decreasing order, the sig-
niﬁcant predictors of SRO risk in the present sample
were: prior SRO, borderline personality disorder, ADHD,
schizotypal disorder, current smoking, former smoking,
avoidant personality disorder and selected demographic
characteristics.
Other than the present one, there have been seven
longitudinal epidemiological studies of smoking and
SRO.
14e20 The positive effect of current smoking on
future SRO reported here was also observed in three
studies.
14e16 Problems of recall due to the long 10-year
interval between data time points could explain the
negative ﬁnding of the study by Kessler et al
17; while
the younger age of the samples in two studies
19 20 could
have masked a future effect. Of clinical and public
health importance is the ﬁnding, ﬁrst reported here,
that longer abstinence from smoking decreased the risk
for SRO. The latter observation, not considered in two
negative studies regarding past smoking,
14 16 could
account for the inconsistent ﬁndings. Notably, the diver-
gence according to longevity of abstinence is consistent
with evidence for lung cancer and other smoking-related
disorders that risk reduction from stopping smoking
occurs only after multiple years of abstinence.
30 31 The
worrisome observation that relapsers and new smokers
are at even higher risk of future SRO than persistent
smokers suggests particular targets for increased thera-
peutic attention. Finally, the data negated a reverse
Table 4 Combined effects of smoking status and prior SRO* reported in wave 1 on a) wave 2 SRO and b) wave 2 current
smoking
Wave 1 smoking status and wave 1 SRO n/N
Weighted
percentages (SE) AORy (95% CI)
a) Effect on wave 2 SRO
Never smokerdno prior SRO (referent) 550/2978 17.5 (0.4) 1.00 (NA)
Never smokerdprior SRO 431/877 46.8 (1.0) 4.12 (3.65 to 4.64)
Former smokerdno prior SRO 187/968 20.6 (0.8) 1.42 (1.28 to 1.57)
Former smokerdprior SRO 152/312 48.2 (1.6) 4.58 (3.60 to 5.82)
Current smokerdno prior SRO 383/1466 26.6 (0.7) 1.56 (1.41 to 1.74)
Current smokerdprior SRO 426/751 54.1 (1.2) 4.77 (3.70 to 5.87)
b) Effect on wave 2 current smoking
Never smokerdno prior SRO (referent) 166/2978 5.3 (0.2) 1.00 (NA)
Never smokerdprior SRO 28/877 4.3 (0.4) 0.70 (0.60 to 0.82)
Former smokerdno prior SRO 71/968 8.6 (0.5) 2.20 (1.77 to 2.31)
Former smokerdprior SRO 24/312 6.9 (0.6) 1.15 (0.83 to 1.61)
Current smokerdno prior SRO 1204/1466 82.7 (0.5) 82.9 (73.7 to 93.2)
Current smokerdprior SRO 620/751 84.2 (0.8) 77.0 (57.6 to 104.8)
*Any of three items: want to die, suicidal ideation, suicide attempt.
yAORs are adjusted ORs with 95% CIs based on multiple logistic regression models controlling for demographics and psychiatric history at
wave 1 (shown in table 1).
SRO, suicide-related outcome.
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Smoking and suicidal behaviourstemporal relationship of SRO on smoking, as also seen in
a study of adolescents.
15 Instead, a reduction in risk for
future smoking was observed among former and never-
smokers with prior SRO in wave 1 compared with their
counterparts without prior SRO. Perhaps among those
former and never smokers, already inclined towards the
pro-health behaviour of not currently smoking, was a
subset spurred by the prior SRO to undertake further
health-promoting and therapeutic actions, which immu-
nised them against future smoking. Their counterparts
who did not experience a prior SRO were less likely to
be as self-protective or to seek counselling and similar
treatments and were less immunised against resorting to
new smoking. The serendipitous observation from the
present sample that prior SRO and treatment seeking
were well correlated (r¼0.43, p¼0.0001) is consistent with
that conjecture.
Strengths and limitations of the study are noted. An
important strength is the concomitance of rigorous
methods and materials not found in prior work on the
smokingesuicide questiondface-to-face interviews, a
longitudinal design, a large sample, a validated instru-
ment and a comprehensive range of putative predictors
that permitted statistical control of key background
factors and comorbidities. A further strength is the use
of a simple yet meaningful measure of smoking status
(ie, never, former or current smoking) that is easy for a
questioner to administer and for the respondent to
recall and understand. Even so, study limitations call for
cautious interpretation of the ﬁndings. The present
sample comprised the subgroup (22%) of wave 2 par-
ticipants (N¼34653) who self-reported low mood during
the 3-year interval between the interviews. This selectivity
yields ﬁndings relevant to mental health settings that are
likely to serve persons experiencing mood problems;
however, they may not generalise to the rest of the
NESARC sample or to the national population. Second,
the sample did not include persons who had completed
suicide attempts. Using the US rate of 11.1 per 100000
population per year,
32 the wave 1 sample of 43093 could
be expected to include about 14 persons with completed
suicides before wave 2 (95% CI 6.8 to 21.6), introducing
a non-trivial, although likely small, selection bias. Third,
the present study did not assess the effects of medical
conditions that are possibly causally related, albeit in
different directions, to smoking and to SRO. Fourth,
self-reported smoking information was not biologically
validated. Fifth, the NESARC did not obtain information
from adolescents, a subgroup with a known high risk for
SRO.
2 Finally, in exploratory unadjusted analyses,
predictive effects of current smoking were observed
across the individual SRO, whereas past smoking pre-
dicted want to die and suicidal ideation but not suicide
attempt. Validation and articulation of these preliminary
observations need to be accomplished in future work.
The rigorous methodology employed in the NESARC
gives eminent credence to the central ﬁndings of this
analysisdan independent effect of smoking on SRO and
the absence of a positive inﬂuence of prior SRO on future
smoking. These results are consistent with the hypothesis
that smoking exerts a contributing, and not simply a
correlational, effect on risk of SRO. By contrast, these
results are inconsistent with the hypothesis that SRO
causes smoking or that a third factor causes both smoking
and SRO. The neurobiological, genetic, psychiatric and
psychological underpinnings of these associations warrant
further investigation. The knowledge gained could
advance prevention and treatment options for reducing
the prevalence of tobacco use and suicide.
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